275 related articles for article (PubMed ID: 32358239)
21. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
Madayag RM; Johnson LB; Bartlett ST; Schweitzer EJ; Constantine NT; McCarter RJ; Kuo PC; Keay S; Oldach DW
Transplantation; 1997 Dec; 64(12):1781-6. PubMed ID: 9422420
[TBL] [Abstract][Full Text] [Related]
22. Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease.
Yu J; Shi X; Yu H; Wu J; Ma J; Dong S; Lu S; Zheng S; Li L; Xu X; Cao H
J Med Virol; 2022 Jul; 94(7):3338-3348. PubMed ID: 35257389
[TBL] [Abstract][Full Text] [Related]
23. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
24. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
[TBL] [Abstract][Full Text] [Related]
25. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
26. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma recurrence is an independent risk factor for HB recurrence after liver transplantation.
Gao PJ; Gao J; Li Z; Hu ZP; Zhu JY
Hepatogastroenterology; 2014 Sep; 61(134):1523-8. PubMed ID: 25436336
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
[TBL] [Abstract][Full Text] [Related]
29. Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria.
Jiang L; Yan LN; Wen TF; Li B; Yang JY
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):494-9. PubMed ID: 24103279
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
[TBL] [Abstract][Full Text] [Related]
31. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of hepatitis B core antibody-positive hepatocellular carcinoma.
Nakai T; Koh K; Kawabe T; Shiraishi O; Okuno K; Yasutomi M
World J Surg; 2002 Jun; 26(6):700-3. PubMed ID: 12053222
[TBL] [Abstract][Full Text] [Related]
33. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
[TBL] [Abstract][Full Text] [Related]
34. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
[TBL] [Abstract][Full Text] [Related]
35. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
36. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
38. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.
Reddy A; May E; Ehrinpreis M; Mutchnick M
World J Gastroenterol; 2013 Dec; 19(48):9328-33. PubMed ID: 24409059
[TBL] [Abstract][Full Text] [Related]
39. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study.
Han SH; Reddy KR; Keeffe EB; Soldevila-Pico C; Gish R; Chung RT; Degertekin B; Lok A;
Clin Transplant; 2011; 25(2):E152-62. PubMed ID: 21077950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
